GT
CDNA icon

Glenmede Trust’s CareDx CDNA Stock Holding History

Glenmede Trust’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,600
Closed -$207K – 1300
2022
Q1 		$207K Buy
+5,600
New +$218K ﹤0.01% 1127
2021
Q4 		– Sell
-17,553
Closed -$1.11M – 1333
2021
Q3 		$1.11M Buy
17,553
+7,192
+69% +$548K 0.01% 675
2021
Q2 		$948K Buy
+10,361
New +$824K ﹤0.01% 716
2020
Q3 		– Sell
-33
Closed -$1K – 2474
2020
Q2 		$1K Buy
+33
New +$939 ﹤0.01% 2314
2019
Q3 		– Sell
-4,200
Closed -$151 – 3020
2019
Q2 		$151 Buy
4,200
+880
+27% +$28.2K ﹤0.01% 1265
2019
Q1 		$104 Buy
3,320
+2,415
+267% +$70.4K ﹤0.01% 1395
2018
Q4 		$22 Buy
+905
New +$23.3K ﹤0.01% 1945

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Glenmede Trust's CDNA Position: Q2 2022 in Review

Glenmede Trust sold out of CareDx (CDNA) in Q2 2022, closing a stake of 5,600 shares — an estimated $207K sold.

Glenmede Trust first reported a position in CDNA in Q4 2018 and held it in 7 quarters. The position peaked at $1.11M in Q3 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Glenmede Trust reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Glenmede Trust sold 5,600 CareDx shares in Q2 2022, an estimated $207K.
  • Glenmede Trust first reported a position in CareDx in Q4 2018 and held it in 7 quarters.
  • Glenmede Trust's CareDx position peaked at $1.11M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.